The role of radiation therapy in the treatment of metastatic cancer

Baldassarre Stea, Tijana Skrepnik, Charles C. Hsu, Roy Abendroth

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Radiation therapy continues to play an important role in the management of cancer. In this review, we discuss the use of radiation therapy to target and control micrometastatic disease (adjuvant use of radiation), or using stereotactic radiation therapy to address small volumes of gross disease, such as oligometastases, and finally the use of radiation therapy in the era of immunotherapy. Radiation therapy is commonly used to treat nodal basins suspected of harboring microscopic disease. More recently, computer and technical innovations have allowed radiation oncologists to treat small volumes of gross disease within the brain and also in the body with great success, adding to the cancer armamentarium. This modality of cancer treatment that began shortly after the discovery of X-rays by William Roentgen continues to evolve and finds new clinical applications which minimize toxicity while increasing effectiveness. The newly discovered interactions of high dose/fraction radiation (stereotactic radiosurgery) with immune check point inhibitors in melanoma is the latest example of how synergism can be achieved between two different modalities thus increasing the therapeutic ratio to control metastatic cancer.

Original languageEnglish (US)
JournalClinical and Experimental Metastasis
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Radiotherapy
Neoplasms
Radiation
Therapeutics
Radiosurgery
Brain Diseases
Immunotherapy
Melanoma
X-Rays

Keywords

  • Adjuvant radiation
  • Immune checkpoint inhibitors
  • Oligometastatic disease
  • Stereotactic radiosurgery
  • Synergism of stereotactic radiosurgery

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The role of radiation therapy in the treatment of metastatic cancer. / Stea, Baldassarre; Skrepnik, Tijana; Hsu, Charles C.; Abendroth, Roy.

In: Clinical and Experimental Metastasis, 01.01.2018.

Research output: Contribution to journalArticle

@article{74abb8f3b39b4211bb97583d624a86ef,
title = "The role of radiation therapy in the treatment of metastatic cancer",
abstract = "Radiation therapy continues to play an important role in the management of cancer. In this review, we discuss the use of radiation therapy to target and control micrometastatic disease (adjuvant use of radiation), or using stereotactic radiation therapy to address small volumes of gross disease, such as oligometastases, and finally the use of radiation therapy in the era of immunotherapy. Radiation therapy is commonly used to treat nodal basins suspected of harboring microscopic disease. More recently, computer and technical innovations have allowed radiation oncologists to treat small volumes of gross disease within the brain and also in the body with great success, adding to the cancer armamentarium. This modality of cancer treatment that began shortly after the discovery of X-rays by William Roentgen continues to evolve and finds new clinical applications which minimize toxicity while increasing effectiveness. The newly discovered interactions of high dose/fraction radiation (stereotactic radiosurgery) with immune check point inhibitors in melanoma is the latest example of how synergism can be achieved between two different modalities thus increasing the therapeutic ratio to control metastatic cancer.",
keywords = "Adjuvant radiation, Immune checkpoint inhibitors, Oligometastatic disease, Stereotactic radiosurgery, Synergism of stereotactic radiosurgery",
author = "Baldassarre Stea and Tijana Skrepnik and Hsu, {Charles C.} and Roy Abendroth",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s10585-018-9926-6",
language = "English (US)",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - The role of radiation therapy in the treatment of metastatic cancer

AU - Stea, Baldassarre

AU - Skrepnik, Tijana

AU - Hsu, Charles C.

AU - Abendroth, Roy

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Radiation therapy continues to play an important role in the management of cancer. In this review, we discuss the use of radiation therapy to target and control micrometastatic disease (adjuvant use of radiation), or using stereotactic radiation therapy to address small volumes of gross disease, such as oligometastases, and finally the use of radiation therapy in the era of immunotherapy. Radiation therapy is commonly used to treat nodal basins suspected of harboring microscopic disease. More recently, computer and technical innovations have allowed radiation oncologists to treat small volumes of gross disease within the brain and also in the body with great success, adding to the cancer armamentarium. This modality of cancer treatment that began shortly after the discovery of X-rays by William Roentgen continues to evolve and finds new clinical applications which minimize toxicity while increasing effectiveness. The newly discovered interactions of high dose/fraction radiation (stereotactic radiosurgery) with immune check point inhibitors in melanoma is the latest example of how synergism can be achieved between two different modalities thus increasing the therapeutic ratio to control metastatic cancer.

AB - Radiation therapy continues to play an important role in the management of cancer. In this review, we discuss the use of radiation therapy to target and control micrometastatic disease (adjuvant use of radiation), or using stereotactic radiation therapy to address small volumes of gross disease, such as oligometastases, and finally the use of radiation therapy in the era of immunotherapy. Radiation therapy is commonly used to treat nodal basins suspected of harboring microscopic disease. More recently, computer and technical innovations have allowed radiation oncologists to treat small volumes of gross disease within the brain and also in the body with great success, adding to the cancer armamentarium. This modality of cancer treatment that began shortly after the discovery of X-rays by William Roentgen continues to evolve and finds new clinical applications which minimize toxicity while increasing effectiveness. The newly discovered interactions of high dose/fraction radiation (stereotactic radiosurgery) with immune check point inhibitors in melanoma is the latest example of how synergism can be achieved between two different modalities thus increasing the therapeutic ratio to control metastatic cancer.

KW - Adjuvant radiation

KW - Immune checkpoint inhibitors

KW - Oligometastatic disease

KW - Stereotactic radiosurgery

KW - Synergism of stereotactic radiosurgery

UR - http://www.scopus.com/inward/record.url?scp=85050982532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050982532&partnerID=8YFLogxK

U2 - 10.1007/s10585-018-9926-6

DO - 10.1007/s10585-018-9926-6

M3 - Article

C2 - 30062507

AN - SCOPUS:85050982532

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

ER -